CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection. by Mary S Pampusch, Hadia M Abdelaal, Emily K Cartwright, Jhomary S Molden, Brianna C Davey, Jordan D Sauve, Emily N Sevcik, Aaron K Rendahl, Eva G Rakasz, Elizabeth Connick, Edward A Berger, Pamela J Skinner

Get full text